0001772230-20-000002.txt : 20200305 0001772230-20-000002.hdr.sgml : 20200305 20200305135755 ACCESSION NUMBER: 0001772230-20-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(7) FILED AS OF DATE: 20200305 DATE AS OF CHANGE: 20200305 EFFECTIVENESS DATE: 20200305 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Redmile Biopharma Investments II, L.P. CENTRAL INDEX KEY: 0001772230 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-335974 FILM NUMBER: 20690288 BUSINESS ADDRESS: STREET 1: LETTERMAN DIGITAL ARTS CENTER STREET 2: ONE LETTERMAN DRIVE, SUITE D3-300 CITY: SAN FRANCISCO STATE: CA ZIP: 94129 BUSINESS PHONE: 415-489-9980 MAIL ADDRESS: STREET 1: LETTERMAN DIGITAL ARTS CENTER STREET 2: ONE LETTERMAN DRIVE, SUITE D3-300 CITY: SAN FRANCISCO STATE: CA ZIP: 94129 D/A 1 primary_doc.xml X0708 D/A LIVE 0001772230 Redmile Biopharma Investments II, L.P. Letterman Digital Arts Center One Letterman Drive, Suite D3-300 San Francisco CA CALIFORNIA 94129 415-489-9980 DELAWARE None None Limited Partnership true 2018 n/a Redmile Biopharma Investments II (GP), LLC Letterman Digital Arts Center One Letterman Drive, Suite D3-300 San Francisco CA CALIFORNIA 94129 Promoter General Partner n/a Redmile Group, LLC Letterman Digital Arts Center One Letterman Drive, Suite D3-300 San Francisco CA CALIFORNIA 94129 Executive Officer Management Company Jeremy Green Redmile Group, LLC One Letterman Drive, Suite D3-300 San Francisco CA CALIFORNIA 94129 Executive Officer Mike Lee Redmile Group, LLC One Letterman Drive, Suite D3-300 San Francisco CA CALIFORNIA 94129 Executive Officer Amrit Nagpal Redmile Group, LLC One Letterman Drive, Suite D3-300 San Francisco CA CALIFORNIA 94129 Executive Officer Pooled Investment Fund Venture Capital Fund false Decline to Disclose 06b 3C 3C.7 true 0001772230-19-000001 2019-03-22 false true false 0 J.P. Morgan Securities LLC 79 None None 383 Madison Avenue New York NY NEW YORK 10179 All States false Hollister Associates, LLC 173366 None None 713 New Market Drive Mt. Pleasant SC SOUTH CAROLINA 29464 AL ALABAMA AZ ARIZONA CA CALIFORNIA CO COLORADO CT CONNECTICUT DE DELAWARE DC DISTRICT OF COLUMBIA FL FLORIDA GA GEORGIA HI HAWAII ID IDAHO IL ILLINOIS IN INDIANA LA LOUISIANA MD MARYLAND MA MASSACHUSETTS MI MICHIGAN MN MINNESOTA MO MISSOURI NV NEVADA NJ NEW JERSEY NM NEW MEXICO NY NEW YORK NC NORTH CAROLINA OH OHIO OK OKLAHOMA OR OREGON PA PENNSYLVANIA RI RHODE ISLAND SC SOUTH CAROLINA SD SOUTH DAKOTA TN TENNESSEE TX TEXAS VA VIRGINIA WA WASHINGTON false 675420000 675420000 0 true 1 137 7300000 0 0 false Redmile Biopharma Investments II, L.P. Rachel Chang Rachel Chang General Counsel of the Management Company 2020-03-05